| 环磷酰胺联合中等剂量泼尼松治疗特发性膜性肾病的临床研究 |
| |
| 引用本文： | 施占琴,丁敏. 环磷酰胺联合中等剂量泼尼松治疗特发性膜性肾病的临床研究[J]. 中华肾脏病杂志, 2006, 25(1): 483-484. DOI: 10.3760/cma.j.issn.1001-7097.2009.06.022 |
| |
| 作者姓名： | 施占琴 丁敏 |
| |
| 作者单位： | 浙江省湖州市第一人民医院肾内科,313000; |
| |
| 摘 要： | 特发性膜性肾病(IMN)是成人肾病综合征最常见的病因之一,占老年人肾病综合征发病率的23%～75%[1],占原发性肾小球肾炎的9.89%[2].
|
Clinical research of medium-dose prednisone combined with cyclophosphamide in the treatment for idiopathic membranous nephropathy |
| |
| SHI Zhan-qin,DING Min. Clinical research of medium-dose prednisone combined with cyclophosphamide in the treatment for idiopathic membranous nephropathy[J]. Chinese Journal of Nephrology, 2006, 25(1): 483-484. DOI: 10.3760/cma.j.issn.1001-7097.2009.06.022 |
| |
| Authors: | SHI Zhan-qin DING Min |
| |
| Abstract: | |
| |
| Keywords: | |
|
|
